| Sudarshan K Sharma, MD | |
|
121 N Elm St, Hinsdale, IL 60521-3703 | |
| (630) 856-6757 | |
| (630) 887-1668 |
| Full Name | Sudarshan K Sharma |
|---|---|
| Gender | Male |
| Speciality | Gynecological Oncology |
| Experience | 52 Years |
| Location | 121 N Elm St, Hinsdale, Illinois |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1740265974 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207VG0400X | Obstetrics & Gynecology - Gynecology | 36054912 (Illinois) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Adventist Hinsdale Hospital | Hinsdale, IL | Hospital |
| Edward Hospital | Naperville, IL | Hospital |
| Elmhurst Memorial Hospital | Elmhurst, IL | Hospital |
| Adventist Bolingbrook Hospital | Bolingbrook, IL | Hospital |
| Morris Hospital & Healthcare Centers | Morris, IL | Hospital |
| Entity Name | Dr Sudarshan K Sharma Ltd |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1821198714 PECOS PAC ID: 1658445895 Enrollment ID: O20080805000912 |
News Archive
Sucampo Pharmaceuticals, Inc. today announced that its wholly owned subsidiary, Sucampo Manufacturing & Research AG, and R-Tech Ueno, Ltd., a pharmaceutical company founded in Japan in 1989, have entered into a license agreement for RESCULA eye drops, expanding Sucampo's rights beyond its previously agreed territory of the United States and Canada to all countries in Europe and the rest of the world except Japan, Korea, Taiwan and the People's Republic of China.
Faron Pharmaceuticals Ltd., Turku, Finland and Priaxon AG, Munich, Germany today announced the entry into a collaboration and commercialization agreement to obtain new superior AOC3/SSAO antagonists. This collaboration combines two world-class technologies, the thorough understanding of the AOC3-protein and its ligand interaction with the rapid discovery engine for the development of new chemical inhibitors of protein-protein interactions.
In this Atlantic opinion piece, Amanda Glassman, director of Global Health Policy at the Center for Global Development (CGD), reports on how lengthy, inefficient review processes for drug and vaccine candidates waiting in the pipeline for late stages of clinical development is keeping promising new medicines, vaccines, and diagnostic techniques from reaching millions in need.
PTC Therapeutics, Inc. today announced the publication of data from a Phase 2a clinical trial of ataluren in children with nonsense mutation cystic fibrosis (nmCF) in the American Journal of Respiratory and Critical Care Medicine.
Thermography has been a hot topic this year, due to the need for quicker diagnostics to detect and prevent the spread of COVID-19.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Sudarshan K Sharma, MD 121 N Elm St, Hinsdale, IL 60521-3703 Ph: (630) 856-6757 | Sudarshan K Sharma, MD 121 N Elm St, Hinsdale, IL 60521-3703 Ph: (630) 856-6757 |
News Archive
Sucampo Pharmaceuticals, Inc. today announced that its wholly owned subsidiary, Sucampo Manufacturing & Research AG, and R-Tech Ueno, Ltd., a pharmaceutical company founded in Japan in 1989, have entered into a license agreement for RESCULA eye drops, expanding Sucampo's rights beyond its previously agreed territory of the United States and Canada to all countries in Europe and the rest of the world except Japan, Korea, Taiwan and the People's Republic of China.
Faron Pharmaceuticals Ltd., Turku, Finland and Priaxon AG, Munich, Germany today announced the entry into a collaboration and commercialization agreement to obtain new superior AOC3/SSAO antagonists. This collaboration combines two world-class technologies, the thorough understanding of the AOC3-protein and its ligand interaction with the rapid discovery engine for the development of new chemical inhibitors of protein-protein interactions.
In this Atlantic opinion piece, Amanda Glassman, director of Global Health Policy at the Center for Global Development (CGD), reports on how lengthy, inefficient review processes for drug and vaccine candidates waiting in the pipeline for late stages of clinical development is keeping promising new medicines, vaccines, and diagnostic techniques from reaching millions in need.
PTC Therapeutics, Inc. today announced the publication of data from a Phase 2a clinical trial of ataluren in children with nonsense mutation cystic fibrosis (nmCF) in the American Journal of Respiratory and Critical Care Medicine.
Thermography has been a hot topic this year, due to the need for quicker diagnostics to detect and prevent the spread of COVID-19.
› Verified 4 days ago
Karenmarie Kathleen Meyer, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 732 Bittersweet Ln, Hinsdale, IL 60521 Phone: 630-789-8354 Fax: 267-695-6549 | |
Dr. William Meyer, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 120 N Oak St, Hinsdale, IL 60521 Phone: 630-856-6741 Fax: 630-856-6746 | |
Dr. Michael E Bercek, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 40 S Clay St Ste 100, Hinsdale, IL 60521 Phone: 630-920-2229 Fax: 630-920-8342 | |
James Carlo Falcone, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 718 N York Rd, Hinsdale, IL 60521 Phone: 630-205-2482 Fax: 630-920-1048 | |
Dr. Daniel Gauthier, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 120 N Oak St, Hinsdale, IL 60521 Phone: 630-856-2218 Fax: 630-856-6746 | |
Dr. Dwight D Kett, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 40 S Clay St Ste 100, Hinsdale, IL 60521 Phone: 630-920-2229 Fax: 630-920-8342 | |
Dr. Pamela E Dorne, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 201 E Ogden Ave Ste 212, Hinsdale, IL 60521 Phone: 708-383-3883 Fax: 888-596-8376 |